Related Experiment Video
Updated: Jun 23, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer
F Slevin1, S Kendal2, A L Appelt1
1Radiotherapy Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|June 20, 2026
Summary
Reirradiation shows promise for recurrent cancers, but more high-quality studies are needed. Clinicians and commissioners support improving evidence and access, with varied views on trial design and technology integration for reirradiation.
Area of Science:
- Oncology
- Radiation Oncology
- Health Services Research
Background:
- Growing interest in reirradiation for recurrent or new primary cancers within previously irradiated areas.
- Need for robust studies to evaluate the safety and efficacy of reirradiation.
- Understanding perspectives on evidence generation and technology's role is crucial.
Purpose of the Study:
- To explore UK clinician and commissioner views on reirradiation.
- To identify optimal methods for generating evidence for reirradiation.
- To assess the potential role of advanced technologies in reirradiation.
Main Methods:
- Semi-structured interviews with 10 UK clinical oncologists and 2 commissioners.
- Thematic analysis of interview data to identify key themes.
- Exploration of perspectives on evidence generation and clinical trial design.
Main Results:
- Six key themes emerged: balancing benefits and uncertainties, patient preferences, need for guidance, availability challenges, evidence base enhancement, and trial design considerations.
- Support for strengthening the evidence base and increasing reirradiation availability.
- Mixed views on clinical trials versus registries or evaluative commissioning for evidence generation; advanced technologies noted but standard photon reirradiation also beneficial.
Conclusions:
- Study offers insights into reirradiation practices and availability improvements.
- Perspectives on trials and advanced technologies should inform future study designs.
- Strengthening the evidence base is essential for advancing reirradiation care.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.